TY - JOUR
T1 - Baseline Gut Microbiota Composition Is Associated with Major Infections Early after Hematopoietic Cell Transplantation
AU - Murthy, Hemant S.
AU - Gharaibeh, Raad Z.
AU - Al-Mansour, Zeina
AU - Kozlov, Andrew
AU - Trikha, Gaurav
AU - Newsome, Rachel C.
AU - Gauthier, Josee
AU - Farhadfar, Nosha
AU - Wang, Yu
AU - Kelly, Debra Lynch
AU - Lybarger, John
AU - Jobin, Christian
AU - Wang, Gary P.
AU - Wingard, John R.
N1 - Funding Information:
Financial disclosure: R.Z.G. is supported by UF Health Cancer Center funds. This work was supported in part by the Gatorade Trust through funds distributed by the University of Florida, Department of Medicine (to G.P.W.), in part by the Infectious Diseases Society of America Medical Scholars Program (to A.K.), and in part by the Price Eminent Scholar endowment (to J. R.W). Conflict of interest statement: J.R.W. has served as a consultant for Shire, Astellas, Celgene, Ansun, Allovir, Pluristem, and Cidara. The other authors have no conflicts of interest to report. Authorship statement: All authors reviewed the manuscript, provided edits, and gave final approval. Current address of GT is Florida Cancer Specialists, St. Augustine, FL and of HSM is Division of Hematology/Oncology, Mayo Clinic Florida, Jacksonville, FL.
Funding Information:
Financial disclosure: R.Z.G. is supported by UF Health Cancer Center funds. This work was supported in part by the Gatorade Trust through funds distributed by the University of Florida, Department of Medicine (to G.P.W.), in part by the Infectious Diseases Society of America Medical Scholars Program (to A.K.), and in part by the Price Eminent Scholar endowment (to J. R.W).
Publisher Copyright:
© 2020 American Society for Transplantation and Cellular Therapy
PY - 2020/11
Y1 - 2020/11
N2 - Infection is a major cause of morbidity and mortality after hematopoietic cell transplantation (HCT). Gut microbiota (GM) composition and metabolites provide colonization resistance against dominance of potential pathogens, and GM dysbiosis following HCT can be deleterious to immune reconstitution. Little is known about the composition, diversity, and evolution of GM communities in HCT patients and their association with subsequent febrile neutropenia (FN) and infection. Identification of markers before HCT that predict subsequent infection could be useful in developing individualized antimicrobial strategies. Fecal samples were collected prospectively from 33 HCT recipients at serial time points: baseline, post-conditioning regimen, neutropenia onset, FN onset (if present), and hematologic recovery. GM was assessed by 16S rRNA sequencing. FN and major infections (ie, bloodstream infection, typhlitis, invasive fungal infection, pneumonia, and Clostridium difficile enterocolitis) were identified. Significant shifts in GM composition and diversity were observed during HCT, with the largest alterations occurring after initiation of antibiotics. Loss of diversity persisted without a return to baseline at hematologic recovery. GM in patients with FN was enriched in Mogibacterium, Bacteroides fragilis, and Parabacteroides distasonis, whereas increased abundance of Prevotella, Ruminococcus, Dorea, Blautia, and Collinsella was observed in patients without fever. A baseline protective GM profile (BPGMP) was predictive of protection from major infection. The BPGMP was associated with subsequent major infections with 77% accuracy and an area under the curve of 79%, with sensitivity, specificity, and positive and negative predictive values of 0.71, 0.91, 0.77, and 0.87, respectively. Our data show that large shifts in GM composition occur early after HCT, and differences in baseline GM composition are associated with the development of subsequent major infections.
AB - Infection is a major cause of morbidity and mortality after hematopoietic cell transplantation (HCT). Gut microbiota (GM) composition and metabolites provide colonization resistance against dominance of potential pathogens, and GM dysbiosis following HCT can be deleterious to immune reconstitution. Little is known about the composition, diversity, and evolution of GM communities in HCT patients and their association with subsequent febrile neutropenia (FN) and infection. Identification of markers before HCT that predict subsequent infection could be useful in developing individualized antimicrobial strategies. Fecal samples were collected prospectively from 33 HCT recipients at serial time points: baseline, post-conditioning regimen, neutropenia onset, FN onset (if present), and hematologic recovery. GM was assessed by 16S rRNA sequencing. FN and major infections (ie, bloodstream infection, typhlitis, invasive fungal infection, pneumonia, and Clostridium difficile enterocolitis) were identified. Significant shifts in GM composition and diversity were observed during HCT, with the largest alterations occurring after initiation of antibiotics. Loss of diversity persisted without a return to baseline at hematologic recovery. GM in patients with FN was enriched in Mogibacterium, Bacteroides fragilis, and Parabacteroides distasonis, whereas increased abundance of Prevotella, Ruminococcus, Dorea, Blautia, and Collinsella was observed in patients without fever. A baseline protective GM profile (BPGMP) was predictive of protection from major infection. The BPGMP was associated with subsequent major infections with 77% accuracy and an area under the curve of 79%, with sensitivity, specificity, and positive and negative predictive values of 0.71, 0.91, 0.77, and 0.87, respectively. Our data show that large shifts in GM composition occur early after HCT, and differences in baseline GM composition are associated with the development of subsequent major infections.
KW - Hematopoietic cell transplantation
KW - Infection
KW - Microbiota
UR - http://www.scopus.com/inward/record.url?scp=85090064148&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090064148&partnerID=8YFLogxK
U2 - 10.1016/j.bbmt.2020.07.023
DO - 10.1016/j.bbmt.2020.07.023
M3 - Article
C2 - 32717434
AN - SCOPUS:85090064148
SN - 1083-8791
VL - 26
SP - 2001
EP - 2010
JO - Biology of Blood and Marrow Transplantation
JF - Biology of Blood and Marrow Transplantation
IS - 11
ER -